Navigation Links
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
Date:1/12/2009

final Phase 3 data from ACHIEVE 1 in March.
  • File global marketing applications in fall.
  • LymphoStat-B(R): On Track for Phase 3 Data in July and November 2009

    In 2008, HGS completed the enrollment of both Phase 3 trials of LymphoStat-B (belimumab) in patients with active systemic lupus erythematosus (SLE). The Company expects to report the first Phase 3 data for LymphoStat-B in July 2009 from the BLISS-52 trial, with results from BLISS-76 anticipated in November 2009. BLISS-52 and BLISS-76 are the largest clinical trials ever conducted in lupus patients - and the only Phase 3 trials in these patients whose design was directly informed by randomized Phase 2 results. LymphoStat-B is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in August 2006.

    "If LymphoStat-B is successful in Phase 3, we expect to file marketing applications in the United States and Europe in the first half of 2010, and we believe it could become the first new drug approved by the FDA for the treatment of lupus in 50 years," said Mr. Watkins. "Patients with SLE need new treatment options; we hope to be able to help meet that need with LymphoStat-B."

    Key goals for LymphoStat-B in 2009:

    • Report Phase 3 data from BLISS-52 in July.
    • Report Phase 3 data from BLISS-76 in November.

    ABthrax(TM): Delivery of 20,000 Doses to U.S. Strategic National Stockpile Expected Early in Year; HGS Confident of Receiving $150 Million in 2009

    HGS has met every milestone to date under its contract with the U.S. Government and is currently awaiting authorization to begin delivery of 20,000 doses of ABthrax (raxibacumab) to the U.S. Strategic National Stockpile for emergency use in treating inhalation anthrax. The Com
    '/>"/>

    SOURCE Human Genome Sciences, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Video: New Research Discovers Independent Brain Networks Control Human Walking
    2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
    3. Enrollment Begins on Human PK Study for Medidur(TM) FA
    4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
    5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
    6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
    7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
    8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
    9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
    10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
    11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... HAMILTON, N.J. , Oct. 22, 2014 ... CLIA-certified, CAP-accredited laboratory which specializes in high ... that it is now offering new Cystic ... including next- generation DNA sequencing platforms. ... a genetically inherited multisystem disorder that affects ...
    (Date:10/22/2014)... Antigen Discovery Inc. (ADi), a privately held ... the receipt of a National Institutes of Health (NIH) ... Institute of Dental and Craniofacial Research (NIDCR). The one-year ... Protein Microarray Chip, which will contain every protein in ... in the development of safe and effective vaccines and ...
    (Date:10/22/2014)... -- AVACEN Medical announced today that its AVACEN 100 ... by the U.S. Food and Drug Administration. This clearance ... Internet for: the temporary relief of joint pain ... sprains . Logo - http://photos.prnewswire.com/prnh/20141021/153513 ... a sophisticated medical device incorporating over 3,000 firmware instructions ...
    Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C. Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests 2Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2
    ... May 11, 2012  Amgen (NASDAQ: AMGN ) ... vice president of Research and Development at Amgen will ... Administration (FDA) stakeholder hearing on biosimilars. Miletich will urge members ... for biosimilars to establish approval standards that advance patient ...
    ... Mylan Inc. (Nasdaq: MYL ) today ... mg, 20 mg, 40 mg and 80 mg in ... has received marketing authorization from each country,s respective health ... is the generic version of Pfizer,s Lipitor® Tablets. This ...
    Cached Medicine Technology:Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars 2Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars 3Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars 4Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars 5Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars 6Mylan Launches Generic LipitorĀ® in Five European Countries 2
    (Date:10/25/2014)... safe and sound is one of the best Halloween treats ... and goody bags have reflective strips that improve visibility to ... Meadowlands Hospital Medical Center in Secaucus, N.J. Trick-or-treaters ... Davis said. He offers these others tips: ... small area of skin first to ensure it doesn,t cause ...
    (Date:10/25/2014)... Background: , In 1998 Bob Savage founded the Connecticut ... the field of establishing recovery community organizations. Bob had ... he retired, he set out to answer a couple questions ... , 1. Where are the people in recovery when ... Can the recovery community be organized to advocate for issues ...
    (Date:10/25/2014)... Minnesota (PRWEB) October 25, 2014 ... testing firm which verifies IT-accessibility for disabled users ... Access Approved® logo to Mackin Educational Resources ... digital resource management system and to the Minnesota ... the "Own Best Medicine" website. ...
    (Date:10/25/2014)... QueenBeeTickets.com has a variety of tickets for ... prices. Bob Seger & The Silver Bullet Band tickets ... are going on sale October 25 and are expected ... browse the selection of tickets for Bob Seger & ... singer is touring North America beginning next month, and ...
    (Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... of transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) ... multidistrict litigation underway in U.S. District Court, Southern ... Motion for Summary Judgment on Punitive Damages in ... Florida plaintiffs. In a ruling issued on October ...
    Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4
    ... Association (PCMA) issued the following response to today,s,statement ... "PCMA member companies have routinely paid clean claims ... so. Before rushing to judgment,on the issue of ... an,independent study to explore this issue generally and ...
    ... the brain that support memory function differs between people ... pressure, and this difference seems to increase when high ... at the American Heart Associations 61st Annual Fall Conference ... does not mean that those with high blood pressure ...
    ... Insurance Industry Proposal Is ,Bad Public Policy, ... health courts by Case Western Reserve University professors ... would be burdensome,prohibitively expensive and would come at ... prepared under a grant from the American Association ...
    ... North Carolina,students interested in earning the doctor of optometry ... on,Optometry sponsored by the N.C. State Education Assistance Authority.,Conferences are ... Carolina State University (Raleigh, NC) - 1 pm - 5 ... Carolina State University in the Talley Student ...
    ... protects against blood loss, study finds , , THURSDAY, Sept. ... to the rescue of trauma victims suffering from heavy ... suggests. , "This is the first scientific study showing ... study author Dr. Marie-Pierre Poloujadoff, an emergency physician at ...
    ... KALAMAZOO, Mich., Sept. 27 Stryker,Corporation (NYSE: ... a resolution,with the United States Attorney,s office in ... consulting practices in the,orthopaedic industry. The investigation began ... March 2005 that requested documents for the,period January ...
    Cached Medicine News:Health News:Memory tasks require more coordinated brain blood flow for people with high blood pressure 2Health News:Memory tasks require more coordinated brain blood flow for people with high blood pressure 3Health News:New Report Says 'Health Courts' Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights 2Health News:Optometry Career Conferences Set for Five N.C. Campuses in October 2Health News:Toxic Shock Drug Might Aid Trauma Victims 2Health News:Toxic Shock Drug Might Aid Trauma Victims 3Health News:Stryker Announces Resolution Related to March 2005 U.S. Department of Justice Subpoena 2
    Bench Top Horizontal (clean bench) Airflow Cabinet...
    ... chamber provides a safe, clean environment ... in accord with USP-797 requirements. HEPA ... 5) cleanliness conditions in the work ... and tilt-up front panel for easy ...
    ... testing at various temperatures, this chamber ... a clean heating unit to maintain ... 140F. Transparent panels allow full visibility, ... access to the work area. Includes ...
    ... and removes chemical fumes, allowing ... Bonded charcoal filters remove most ... safe exhaust flow speed = ... opening. Includes air speed monitor, ...
    Medicine Products: